@misc{indiciae7c81993d6aed,
  title = {NIH's dedicated K23 trial pathway was associated with more K-trial leadership but no detectable gain in new trials},
  author = {Wang, H. and Fu, H. and Tian, Z.},
  year = {2026},
  doi = {10.64898/2026.10.09.758109},
  url = {https://www.biorxiv.org/content/10.64898/2026.10.09.758109v1},
  note = {Source identifier: 10.64898/2026.10.09.758109}
}